CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
efficacy of INO-5401 and INO-9012 in combination with cemiplimab (REGN2810), with radiation and chemotherapy, in subjects with newly-diagnosed glioblastoma...
Phase 1, Phase 2
Pittsburgh, Pennsylvania, United States and 20 other locations
Glioblastoma (GBM) adaptive, global, innovative learning environment (GBM AGILE) is an international, seamless Phase II/II....
Phase 2, Phase 3
Pittsburgh, Pennsylvania, United States and 61 other locations
This research study is studying several investigational drugs as a possible treatment for Glioblastoma (GBM).The drugs involved in ...
Phase 2
Pittsburgh, Pennsylvania, United States and 11 other locations
The purpose of this first-in-human (FIH) study of \[177Lu\]-NeoB is to characterize the safety, tolerability, pharmacokinetics (PK) as well as the di...
Phase 1, Phase 2
Pittsburgh, Pennsylvania, United States and 13 other locations
To test the effectiveness and safety of Optune® given concomitantly with radiation therapy (RT) and temozolomide (TMZ) in newly diagnosed GBM...
Pittsburgh, Pennsylvania, United States and 132 other locations
A Dose Finding Study of \[177Lu\]Lu-DOTA-TATE in Newly Diagnosed Glioblastoma in Combination with Standard of Care and in Recurrent Glioblastoma...
Phase 1
Pittsburgh, Pennsylvania, United States and 13 other locations
This study will test an investigational drug called AZD1390 in combination with radiation therapy for the treatment of brain tumors. This is the firs...
Phase 1
Pittsburgh, Pennsylvania, United States and 11 other locations
in male and female patients aged 18 to 75 with newly diagnosed glioblastoma.This treatment will be carried out in addition to the maximal su...
Phase 1, Phase 2
Pittsburgh, Pennsylvania, United States
Clinical trials
Research sites
Resources
Legal